{"product_id":"an-introduction-to-pharmacovigilance-isbn-9781119289746","title":"An Introduction to Pharmacovigilance","description":"\u003cp\u003ePharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problems.\u003c\/p\u003e \u003cbr\u003eThis introductory guide is designed to aid the rapid understanding of the key principles of pharmacovigilance. Packed full of examples illustrating drug safety issues it not only covers the processes involved, but the regulatory aspects and ethical and societal considerations of pharmacovigilance. \u003cbr\u003e\u003cbr\u003eCovering the basics step-by-step, this book is perfect for beginners and is essential reading for those new to drug safety departments and pharmaceutical medicine students. The second edition is thoroughly revised and updated throughout and includes a new chapter on clinical aspects of pharmacovigilance. \u003cp\u003eForeword ix\u003c\/p\u003e \u003cp\u003ePreface to the Second Edition xi\u003c\/p\u003e \u003cp\u003ePreface to the First Edition xiii\u003c\/p\u003e \u003cp\u003eAcknowledgements xv\u003c\/p\u003e \u003cp\u003eList of Abbreviations xvii\u003c\/p\u003e \u003cp\u003e1 What is Pharmacovigilance and How Has it Developed? 1\u003c\/p\u003e \u003cp\u003e2 Basic Concepts 19\u003c\/p\u003e \u003cp\u003e3 Types and Sources of Data 37\u003c\/p\u003e \u003cp\u003e4 The Process of Pharmacovigilance 55\u003c\/p\u003e \u003cp\u003e5 Regulatory Aspects of Pharmacovigilance 75\u003c\/p\u003e \u003cp\u003e6 International Collaboration 95\u003c\/p\u003e \u003cp\u003e7 Clinical Aspects of Adverse Drug Reactions 109\u003c\/p\u003e \u003cp\u003e8 Ethical and Societal Considerations 123\u003c\/p\u003e \u003cp\u003e9 Future Directions 135\u003c\/p\u003e \u003cp\u003e10 Learning More About Pharmacovigilance 145\u003c\/p\u003e \u003cp\u003eGlossary 151\u003c\/p\u003e \u003cp\u003eIndex 157\u003c\/p\u003e   \u003cp\u003e\u003cb\u003e Patrick Waller MD, MPH, FRCPEd, FFPM,\u003c\/b\u003e Formerly Honorary Professor, London School of Hygiene and Tropical Medicine, London, United Kingdom.   \u003c\/p\u003e\u003cp\u003e\u003cb\u003e Mira Harrison-Woolrych BM, DM, DFFP, FRCOG,\u003c\/b\u003e Honorary Research Associate Professor, Dunedin School of Medicine, University of Otago, New Zealand; Senior Medical Assessor, Vigilance and Risk Management, Medicines and Healthcare products Regulatory Agency (MHRA), London, UK and Secretary General of the International Society of Pharmacovigilance (ISoP).      \u003c\/p\u003e\u003cp\u003e Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problems.   \u003c\/p\u003e\u003cp\u003e This introductory guide is designed to aid the rapid understanding of the key principles of pharmacovigilance. Packed full of examples illustrating drug safety issues it not only covers the processes involved, but the regulatory aspects and ethical and societal considerations of pharmacovigilance.   \u003c\/p\u003e\u003cp\u003e Covering the basics step-by-step, this book is perfect for beginners and is essential reading for those new to drug safety departments and pharmaceutical medicine students. The second edition is thoroughly revised and updated throughout and includes a new chapter on clinical aspects of pharmacovigilance.   \u003c\/p\u003e\u003cp\u003e\u003ci\u003e \"This new edition of a clear and succinct yet comprehensive guide to the field provides exactly the right introduction for those new to the challenges and the excitement of pharmacovigilance. It conveys the importance to public health protection of an effective safety net to pick up new information, and the need for well-planned strategies to generate new evidence as an enabler of innovation.\" \u003c\/i\u003e  \u003c\/p\u003e\u003cp\u003e -From the Foreword by \u003cb\u003eDr June Raine CBE,\u003c\/b\u003e Director of Vigilance and Risk Management of Medicines, Medicines and Healthcare Products Regulatory Agency, London, UK and Chair of the EU Pharmacovigilance Risk Assessment Committee.   \u003c\/p\u003e\u003cp\u003e\u003cb\u003e Praise for the first edition \u003c\/b\u003e\u003cbr\u003e\u003ci\u003e \"The book is small in size, attractively produced, and... accessible to all. It does not assume any prior knowledge, yet it also manages to be informative for those who are already familiar with pharmacovigilance. I strongly recommend anyone involved with any type of post-marketing medication research, or any epidemiological study which includes medication use, to read this interesting little book.\" \u003c\/i\u003e  \u003c\/p\u003e\u003cp\u003e\u003cb\u003e -C. Ineke Neutel,\u003c\/b\u003e University of Ottawa (Annals of Epidemiology, December 2010)\u003c\/p\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47988728889573,"sku":"NP9781119289746","price":41.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781119289746.jpg?v=1761781357","url":"https:\/\/k12savings.com\/es\/products\/an-introduction-to-pharmacovigilance-isbn-9781119289746","provider":"K12savings","version":"1.0","type":"link"}